Arbutus Biopharma Corporation
Arbutus Biopharma Corporation scores highest on Torque (85) and lowest on Earnings (44). Its PosiPenta is 66.02 out of 100, better than most similar companies.
On the Penta Grid this week, Arbutus Biopharma Corporation is Grid #50 of 837 in the Healthcare sector in United States, and Grid #168 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Arbutus Biopharma Corporation | 66.02 | 67 | 44 | 72 | 85 | 63 |
| OrthoPediatrics Corp. | 55.20 | 32 | 49 | 81 | 53 | 62 |
| Candel Therapeutics, Inc. | 40.79 | 14 | 50 | 62 | 34 | 44 |
| Pacific Biosciences of California, Inc. | 28.28 | 0 | 44 | 52 | 2 | 44 |
| Ginkgo Bioworks Holdings, Inc. | 39.65 | 32 | 33 | 60 | 30 | 43 |
| 4D Molecular Therapeutics, Inc. | 42.50 | 32 | 19 | 73 | 52 | 37 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 5.34 |
| P/B ratio | 2.50 |
EEarnings
| Trailing EPS | ₹74.82 |
| Forward EPS | ₹-15.65 |
NNitro
| Price | 399.70 |
| 52-week high | 516.20 |
| 52-week low | 331.50 |
| Fall from 52-week high | 22.6% |
TTorque
| Return on equity (ROE) | 89.58% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.76 |
| Market cap | ₹6,126 Cr |
| Insider holding | 15.92% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Arbutus Biopharma Corporation's PosiPenta score?
Arbutus Biopharma Corporation's PosiPenta is 66.02 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Arbutus Biopharma Corporation stand on the Penta Grid?
On the Penta Grid this week, Arbutus Biopharma Corporation is Grid #50 of 837 in the Healthcare sector in United States, and Grid #168 of 4,000 in United States.
Which PosiPenta pillar is strongest for Arbutus Biopharma Corporation?
Torque (durability), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Arbutus Biopharma Corporation?
Earnings (growth), with a score of 44 out of 100: around the middle of similar companies.
Has Arbutus Biopharma Corporation's PosiPenta changed since last week?
Yes, it rose 1.23 points, from 64.79 to 66.02.
PositoAI is for research and education only and is not investment advice.